Prof. Frenel is a Medical Oncologist at the Institut de Cancerologie de L’Ouest in Nantes France. He is a professor of medicine at Nantes University and a member of the Board of the GINECO group.

Prof. Jean-Sebastien Frenel has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Astra Zeneca, GSK, Esai, MSD, Lilly, Pfizer, Novartis, Daichi Sankyon, Seagen, ABBVIE, ROCHE, Pharma End, Boehringer